Baarine, M., et al. (2009) Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): Potential models for the study of peroxisomal disorders associated with dysmyelination processes. Journal of Neurochemistry, 111, 119-131. doi:10.1111/j.1471-4159.2009.06311.x

has been cited by the following article:

• TITLE: Modulation of peroxisomes abundance by argan oil and lipopolysaccharides in acyl-CoA oxidase 1-deficient fibroblasts

  AUTHORS: Riad El Kebbaj, Soufiane El Kamouni, Hammam I. El Hajj, Pierre Andreoletti, Joseph Gresti, Norbert Latruffe, M’Hammed Saïd El Kebbaj, Joseph Vamecq, Gérard Lizard, Boubker Nasser, Mustapha Cherkaoui-Malki

  KEYWORDS: Acyl-CoA Oxidase 1; Argan Oil; LPS; PGC-1a; Peroxisome Proliferation; P-NALD; PPARa

  JOURNAL NAME: Health, Vol.5 No.1, January 11, 2013

  ABSTRACT: Pseudo-neonatal adrenoleukodystrophy (P-NALD) is a neurodegenerative disorder caused by acyl-CoA oxidase 1 (ACOX1) deficiency with subsequent impairment of peroxisomal fatty acid β-oxidation, accumulation of very long chain fatty acids (VLCFAs) and strong reduction in peroxisome abundance. Increase in peroxisome number has been previously suggested to improve peroxisomal disorders, and in this perspective, the present work was aimed at exploring whether modulation of peroxisomes abundance could be achieved in P-NALD fibroblasts. Here we showed that treatment with the natural Argan oil induced peroxisome proliferation in P-NALD fibroblasts. This induction was independent on activations of both nuclear receptor PPARα and its coactivator PGC-1α. Lipopolysaccharides (LPS) treatment, which caused inflammation, induced also a peroxisome proliferation that, in contrast, was dependent on activations of PPARα and PGC-1α. By its ability to induce peroxisome proliferation, Argan oil is suggested to be of potential therapeutic use in patients with P-NALD.